- Exchange: Natl India
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for Ind-Swift Ltd (INSW)
| Open: | 8.30 | Day's Range: | 8.30 - 9.05 | Volume: | 26,312 |
|---|---|---|---|---|---|
| Previous Close: | 8.65 | 52wk Range: | 7.00 - 24.55 | 1-Yr Rtn: | -62.79% |
Key Statistics for INSW
| Current P/E Ratio (ttm) | 0.9133 |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SENSEX | 0.0570 |
| Earnings Per Share (ttm) | 9.8000 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M INR) | 413.30 |
| Shares Outstanding (M) | 46.18 |
| 30 Day Average Volume | 21,310 |
| Price/Book (mrq) | 0.1145 |
| Price/Sale (ttm) | 0.0345 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend (INR) | 0.4000 |
| Last Dividend | 09/21/2011 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 05/28/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for INSW
No data available
Company Profile & Key Executives for INSW
Ind Swift Ltd. develops and manufactures pharmaceuticals. The Company produces analgesics, antiallergics, anti fungals, anti hypertensives, anti-ulcers, anti-bacterials, corticosteriods, expectorants, vitamins and minerals, nasal decongestants, and specialty herbal remedies.
| S R MehtaChairman | Gopal MunjalCEO/Managing Director |
| V R MehtaJoint Managing Director | Amit TarafderVP:Finance |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
INSW News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page